DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc.

XRAYยทNASDAQ

$9.64

-3.8%
HealthcareMedical - Instruments & Supplies

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.

At a Glance

Live Snapshot
Market Cap$1.93B
EPS-3.0000
P/E Ratio-3.21
Earnings Date08/06/2026
xray

DENTSPLY SIRONA Inc. Street Expectations Map

XRAY ยท NASDAQ

Wall Street analysts project that XRAY stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 13.75, with estimates ranging from a low of 12.00 to a high of 17.00.

Lowest Target
12.00
24.48%
Consensus Target
13.75
42.63%
Highest Target
17.00
76.35%

The consensus 1-year price target stands at 13.75, with estimates ranging from a low of 12.00 to a high of 17.00.

Analyst Consensus Analysis

Upside Potential

+42.6%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

36.4% spread

Good consensus alignment. Moderate target spread reflects general agreement on value drivers with some variance in assumptions.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

xray

DENTSPLY SIRONA Inc. Forward Estimates of Revenue

XRAY ยท NASDAQ
Latest Revenue
3.68B
FY 2025
Avg Estimate
3.68B
FY 2026
Estimate Range
3.62B - 3.76B
Analyst Spread

Forward Growth Analysis

Projected Growth-0.1%

Declining expectations indicate headwindsโ€”investigate whether temporary or structural issues.

Analyst Coverage13 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread4%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

xray

DENTSPLY SIRONA Inc. Forward Estimates of Net Income

XRAY ยท NASDAQ
Latest Net Income
-598.00M
FY 2025
Avg Estimate
305.65M
FY 2026
Estimate Range
243.25M - 368.05M
Analyst Spread

Forward Growth Analysis

Projected Growth+151.1%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage13 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread41%

Wide estimate range reveals significant forecast uncertainty and potential volatility.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

High forecast uncertainty: Wide estimate range indicates analysts struggling to predict outcomesโ€”suggests elevated risk and potential volatility.

xray

DENTSPLY SIRONA Inc. Forward Estimates of EPS

XRAY ยท NASDAQ
Latest EPS
-3.00
FY 2025
Avg Estimate
$1.58
FY 2026
Estimate Range
$1.20 - $1.81
Analyst Spread

Forward Growth Analysis

Projected Growth+152.7%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage11 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread39%

Wide estimate range reveals significant forecast uncertainty and potential volatility.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

xray

DENTSPLY SIRONA Inc. Forward Estimates of EBIT

XRAY ยท NASDAQ
Latest EBIT
-398.00M
FY 2025
Avg Estimate
-266.63M
FY 2026
Estimate Range
-272.41M - -262.29M
Analyst Spread

Forward Growth Analysis

Projected Growth+33.0%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage13 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread4%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

xray

DENTSPLY SIRONA Inc. Forward Estimates of EBITDA

XRAY ยท NASDAQ
Latest EBITDA
-46.00M
FY 2025
Avg Estimate
59.75M
FY 2026
Estimate Range
58.78M - 61.05M
Analyst Spread

Forward Growth Analysis

Projected Growth+229.9%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage13 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread4%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

xray

DENTSPLY SIRONA Inc. Forward Estimates of SG&A Expense

XRAY ยท NASDAQ
Latest SG&A Expense
1.44B
FY 2025
Avg Estimate
1.46B
FY 2026
Estimate Range
1.44B - 1.50B
Analyst Spread

Forward Growth Analysis

Projected Growth+1.8%

Flat growth suggests market maturity or near-term challenges offsetting expansion efforts.

Analyst Coverage13 Analysts

Good analyst coverage ensures reliable estimates with diverse professional perspectives.

Estimate Spread4%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

xray

DENTSPLY SIRONA Inc. Insider Positioning

XRAY ยท NASDAQ

During the last 12 months, insiders have purchased $1.12M and sold $916K worth of XRAY shares, resulting in $208K of net buying activity.

3 Months

Bought

20.0K

249.07K

Sold

0

0.00

Net Activity

+249K

+$249K

3-6 Months

Bought

55.0K

774.72K

Sold

82.2K

915.71K

Net Activity

-141K

-$141K

6-9 Months

Bought

9.3K

100.00K

Sold

0

0.00

Net Activity

+100K

+$100K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
LGT

Lucier Gregory T

Director

65.0K sharesโ€ข3 transactions

$894K

2
FJD

Forbes James D

Director

10.0K sharesโ€ข2 transactions

$130K

3
VLF

Varon Leslie F

Director

9.3K sharesโ€ข1 transactions

$100K

Top Sellers

1
LGT

Lucier Gregory T

Director

82.2K sharesโ€ข1 transactions

$916K

Insider Activity Analysis

Net Insider Sentiment

Bullish

Moderately bullish with $208K net buying. Insiders show cautious optimism through measured share purchases.

Buy/Sell Ratio

1.23:1

Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.

Recent Trend (3 Months)

$249K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

3 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Broad-based insider buying: When multiple insiders independently decide to purchase shares, it often reflects genuine confidence rather than coordinated optics. This pattern deserves attention, especially if buying followed a price decline.